Hormone effects on muscarinic cholinergic binding in bovine and rat sympathetic superior cervical ganglia

Life Sci. 1983 Feb 28;32(9):965-72. doi: 10.1016/0024-3205(83)90926-8.


Muscarinic receptors were assessed by [3H]-quinuclidinyl benzilate (QNB) binding in 900 xg supernatants of bovine superior cervical ganglia (SCG). At 30 degrees C half maximal binding was reached within 3 min and equilibrium within 30 min. Scatchard analysis revealed a single population of binding sites with dissociation constant (Kd) = 0.15 +/- 0.01 nM and site concentration (Bmax) = 101 +/- 4 fmoles/mg prot. Binding was specific for muscarinic drugs. Incubation of bovine SCG with different hormones (10(-7)M) indicated that LH, TRH and testosterone depressed significantly Bmax, and that prolactin decreased both Kd and Bmax of [3H] -QNB binding. Several other hormones tested (TSH, GH, FSH, LHRH, angiotensin II, bradykinin, melatonin, estradiol, thyroxine and triiodothyronine) did not affect QNB binding. Hormone effects were not due to a direct interference with radioligand binding to membrane. The injection of LH to orchidectomized rats depressed Bmax of SCG QNB binding without changing the Kd. These results suggest that muscarinic cholinergic neurotransmission in SCG may be affected by hormones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle
  • Female
  • Ganglia, Sympathetic / drug effects
  • Ganglia, Sympathetic / metabolism*
  • Hormones / pharmacology*
  • Luteinizing Hormone / pharmacology
  • Male
  • Prolactin / pharmacology
  • Quinuclidinyl Benzilate / metabolism
  • Rats
  • Rats, Inbred Strains
  • Receptors, Cholinergic / metabolism*
  • Receptors, Muscarinic / drug effects
  • Receptors, Muscarinic / metabolism*
  • Testosterone / pharmacology
  • Thyrotropin-Releasing Hormone / pharmacology


  • Hormones
  • Receptors, Cholinergic
  • Receptors, Muscarinic
  • Testosterone
  • Thyrotropin-Releasing Hormone
  • Quinuclidinyl Benzilate
  • Prolactin
  • Luteinizing Hormone